top of page
Investment Objective
The Evestia Large Cap Value SMA equally weights 30 stocks of high quality companies that are trading at a discount to the market and paying consistent dividends. Unlike traditional value strategies, this strategy makes risk reduction a key priority for added stability and reliability.
Performance
As of
3-31-25
YTD
1 Yr
2 Yr
3 Yr
Inception
Evestia Mega Cap Value
8.20%
13.06%
9.16%
6.73%
6.76%
iShares Russell 1000 Value
2.07%
7.05%
13.39%
6.44%
5.69%
S&P 500
-4.27%
8.28%
18.59%
9.07%
6.79%
Past performance is not indicative of future results. Evestia live model performance is net of 35 bps platform and strategy fees, but not advisory fees or trading costs. Returns are hypothetical and do not reflect the actual performance of any particular account. For professional investor use only.
Portfolio Statistics*
As of
3-31-25
Evestia Large Cap Value
iShares Russell 1000 Value
Alpha
1.41%
0.00
Beta
0.72
1.00
Sharpe Ratio
0.2
0.1
Upside Capture Ratio
72%
100%
Downside Capture Ratio
69%
100%
Standard Deviation
13.68%
16.47%
Risk Adjusted Returns (%)*
As of
3-31-25
Evestia Large Cap Value
iShares Russell 1000 Value
*Since Inception
Portfolio
Top 10 Holdings
As of
3-31-25
Allstate Corp (The)
3.3%
CVS Health Corp
3.3%
Exxon Mobil Corp
3.3%
Johnson & Johnson
3.3%
Kimberly-Clark Corp
3.3%
Lockheed Martin Corp
3.3%
Portfolio Characteristics
Average Market Cap (Bln)
65.6
Dividend Yield
2.89%
P/E Forward (12m)
13.58
5 Yr Growth
6.37
Return on Equity
17.86
Number of Holdings
30
As of
3-31-25
Merck & Co Inc
3.3%
Procter & Gamble Co (The)
3.3%
Verizon Communications Inc
3.3%
Walmart Inc
3.3%
Sector Exposure
Utilities
13.33%
As of
3-31-25
Consumer Defensive
23.4%
Healthcare
16.66%
Communication Services
3.3%
Technology
3.3%
Consumer Cyclical
6.7%
Financial Services
13.3%
Real Estate
0.0%
Basic Materials
0.0%
Industrials
16.7%
Energy
3.3%
Learn more about Evestia's Large Cap Strategies.
bottom of page